Podiatrie S.R.L.
- Address
- Strada Vlad Tepes 1, 400398 Cluj Napoca, Romania
Podiatrie S.R.L. - Diabetic Foot Infection Research Center
Podiatrie S.R.L. is a specialized clinical research facility focused on advancing treatment options for complex lower extremity complications. The center demonstrates particular expertise in conducting sophisticated Phase 3 multicenter trials evaluating novel antimicrobial therapies for serious podiatric conditions.
- Diabetic foot infections and related complications
- Advanced antimicrobial therapy evaluation and safety assessment
- Comparative efficacy studies of intravenous and oral antibiotic regimens
The research team at Podiatrie S.R.L. specializes in managing and studying moderate to severe diabetic foot infections, with extensive experience in randomized, double-blind clinical trial methodologies. Their work focuses on evaluating both the safety and efficacy of emerging antibiotic treatments, including novel agents such as contezolid acefosamil compared to standard therapies like linezolid. This expertise positions the center as a key contributor to developing improved therapeutic strategies for patients suffering from challenging diabetic complications.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Micurx Pharmaceuticals Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Podiatrie S.R.L.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections | Micurx Pharmaceuticals Inc. | Phase III | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aztreonam | 1 | Unknown | 2023-03-17 | 2023-03-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.